Insider Transactions in Q4 2021 at Novavax Inc (NVAX)
Insider Transaction List (Q4 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 12
2021
|
Gregory M Glenn President, R&D |
SELL
Open market or private sale
|
Direct |
8,250
-16.21%
|
$1,353,000
$164.07 P/Share
|
|
Oct 12
2021
|
Gregory M Glenn President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,250
+40.12%
|
$156,750
$19.08 P/Share
|
|
Oct 05
2021
|
Gregory M Glenn President, R&D |
SELL
Open market or private sale
|
Direct |
8,250
-8.73%
|
$1,452,000
$176.83 P/Share
|
|
Oct 05
2021
|
Gregory M Glenn President, R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,250
+40.12%
|
$156,750
$19.08 P/Share
|
|
Oct 04
2021
|
Stanley C Erck President and CEO |
SELL
Open market or private sale
|
Direct |
42,829
-9.5%
|
$7,495,075
$175.55 P/Share
|
|
Oct 04
2021
|
Stanley C Erck President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
42,829
+25.19%
|
$1,156,383
$27.3 P/Share
|
|
Oct 01
2021
|
John A Herrmann Iii EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
5,000
-6.58%
|
$875,000
$175.55 P/Share
|
|
Oct 01
2021
|
John A Herrmann Iii EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+39.19%
|
$95,000
$19.08 P/Share
|
|
Oct 01
2021
|
Stanley C Erck President and CEO |
SELL
Open market or private sale
|
Direct |
49,000
-4.65%
|
$8,624,000
$176.63 P/Share
|
|
Oct 01
2021
|
Stanley C Erck President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
49,000
+29.71%
|
$1,323,000
$27.3 P/Share
|